Dolby Laboratories, Inc. (DLB) DCF Valuation

Dolby Laboratories, Inc. (DLB) DCF Valuation

US | Technology | Information Technology Services | NYSE
Dolby Laboratories, Inc. (DLB) DCF Valuation

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

Dolby Laboratories, Inc. (DLB) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Engineered for exactness, our Dolby Laboratories, Inc. (DLB) DCF Calculator empowers you to assess Dolby's valuation using real-time financial data, providing complete flexibility to modify all essential parameters for enhanced projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
AY4
2023
AY5
2024
FY1
2025
FY2
2026
FY3
2027
FY4
2028
FY5
2029
Revenue 1,161.8 1,281.3 1,253.8 1,009.2 1,273.7 1,321.0 1,370.0 1,420.8 1,473.6 1,528.2
Revenue Growth, % 0 10.28 -2.14 -19.51 26.21 3.71 3.71 3.71 3.71 3.71
EBITDA 332.6 464.1 329.9 219.2 258.3 351.8 364.9 378.4 392.5 407.0
EBITDA, % 28.63 36.22 26.31 21.73 20.28 26.63 26.63 26.63 26.63 26.63
Depreciation 113.9 119.7 123.3 71.3 87.3 113.3 117.5 121.9 126.4 131.1
Depreciation, % 9.8 9.34 9.83 7.06 6.86 8.58 8.58 8.58 8.58 8.58
EBIT 218.7 344.4 206.6 148.0 171.0 238.5 247.4 256.5 266.1 275.9
EBIT, % 18.83 26.88 16.48 14.66 13.43 18.05 18.05 18.05 18.05 18.05
Total Cash 1,118.8 1,264.2 809.3 884.5 482.0 1,017.2 1,054.9 1,094.1 1,134.7 1,176.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 341.7 414.9 419.7 444.4 315.5
Account Receivables, % 29.41 32.38 33.47 44.03 24.77
Inventories 25.6 11.0 23.5 35.6 33.7 29.4 30.4 31.6 32.7 34.0
Inventories, % 2.2 0.8558 1.88 3.53 2.65 2.22 2.22 2.22 2.22 2.22
Accounts Payable 12.6 17.8 14.2 20.9 17.4 18.6 19.3 20.0 20.8 21.5
Accounts Payable, % 1.09 1.39 1.13 2.07 1.36 1.41 1.41 1.41 1.41 1.41
Capital Expenditure -69.0 -54.5 -59.5 -22.2 -30.0 -51.5 -53.4 -55.4 -57.4 -59.5
Capital Expenditure, % -5.94 -4.25 -4.74 -2.2 -2.36 -3.9 -3.9 -3.9 -3.9 -3.9
Tax Rate, % -15.41 -15.41 -15.41 -15.41 -15.41 -15.41 -15.41 -15.41 -15.41 -15.41
EBITAT 211.1 301.4 176.7 117.6 197.4 214.2 222.1 230.4 238.9 247.8
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -98.6 313.2 219.6 136.7 381.9 163.6 269.8 279.8 290.2 300.9
WACC, % 8.97 8.93 8.92 8.89 8.99 8.94 8.94 8.94 8.94 8.94
PV UFCF
SUM PV UFCF 996.0
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 313
Terminal Value 6,333
Present Terminal Value 4,127
Enterprise Value 5,123
Net Debt -435
Equity Value 5,558
Diluted Shares Outstanding, MM 97
Equity Value Per Share 57.11

What You Will Get

  • Real DLB Financial Data: Pre-filled with Dolby’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Dolby’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Customizable Audio Settings: Adjust essential parameters like sound quality, volume levels, and surround sound options.
  • Instant Sound Analysis: Provides real-time audio performance metrics and insights.
  • Industry-Leading Precision: Leverages Dolby’s advanced technology for unparalleled audio experiences.
  • Effortless Compatibility Testing: Easily evaluate how audio setups perform across different devices and environments.
  • Efficiency Booster: Streamlines the audio optimization process, reducing the need for extensive manual adjustments.

How It Works

  • 1. Access the Template: Download and open the Excel file featuring Dolby Laboratories, Inc. (DLB) preloaded data.
  • 2. Modify Assumptions: Adjust essential inputs such as growth projections, WACC, and capital expenditures.
  • 3. Analyze Results Instantly: The DCF model automatically computes intrinsic value and NPV based on your inputs.
  • 4. Evaluate Scenarios: Test various forecasts to explore different valuation possibilities.
  • 5. Present with Assurance: Share professional valuation insights to enhance your decision-making process.

Why Choose This Calculator?

  • Accurate Data: Real Dolby Laboratories financials ensure reliable valuation results.
  • Customizable: Adjust key parameters like growth rates, WACC, and tax rates to match your projections.
  • Time-Saving: Pre-built calculations eliminate the need to start from scratch.
  • Professional-Grade Tool: Designed for investors, analysts, and consultants.
  • User-Friendly: Intuitive layout and step-by-step instructions make it easy for all users.

Who Should Use This Product?

  • Investors: Evaluate Dolby’s valuation before making stock transactions.
  • CFOs and Financial Analysts: Optimize valuation workflows and assess financial forecasts.
  • Startup Founders: Understand how established companies like Dolby are appraised.
  • Consultants: Create detailed valuation reports for your clients.
  • Students and Educators: Utilize real-world data to learn and teach valuation methodologies.

What the Dolby Template Contains

  • Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for Dolby Laboratories, Inc. (DLB).
  • Real-World Data: Dolby’s historical and projected financials preloaded for in-depth analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Interactive charts and tables for clear, actionable results.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.